These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17616687)

  • 21. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation.
    Yan T; Schupp JE; Hwang HS; Wagner MW; Berry SE; Strickfaden S; Veigl ML; Sedwick WD; Boothman DA; Kinsella TJ
    Cancer Res; 2001 Nov; 61(22):8290-7. PubMed ID: 11719462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
    Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
    Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gadd45 mediated G2/M cell cycle arrest induced by BRCA1].
    Song YM; Tong T; Fu M; Dong LJ; Jin SQ; Wu M; Zhan QM
    Ai Zheng; 2004 May; 23(5):517-21. PubMed ID: 15142446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell lines.
    Slebos RJ; Taylor JA
    Biochem Biophys Res Commun; 2001 Feb; 281(1):212-9. PubMed ID: 11178982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysfunctional BRCA1 is only indirectly linked to multiple centrosomes.
    Hut HM; Rembacz KP; van Waarde MA; Lemstra W; van Cappellen WA; Kampinga HH; Sibon OC
    Oncogene; 2005 Nov; 24(51):7619-23. PubMed ID: 16205648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single cell tracking reveals that Msh2 is a key component of an early-acting DNA damage-activated G2 checkpoint.
    Marquez N; Chappell SC; Sansom OJ; Clarke AR; Court J; Errington RJ; Smith PJ
    Oncogene; 2003 Oct; 22(48):7642-8. PubMed ID: 14576827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of DNA mismatch repair in drug resistance.
    Fink D; Aebi S; Howell SB
    Clin Cancer Res; 1998 Jan; 4(1):1-6. PubMed ID: 9516945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents.
    Vernole P; Pepponi R; D'Atri S
    Cancer Chemother Pharmacol; 2003 Sep; 52(3):185-92. PubMed ID: 12827294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
    DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
    Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signalling cell cycle arrest and cell death through the MMR System.
    O'Brien V; Brown R
    Carcinogenesis; 2006 Apr; 27(4):682-92. PubMed ID: 16332722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probabilistic modeling of DNA mismatch repair effects on cell cycle dynamics and iododeoxyuridine-DNA incorporation.
    Gurkan E; Schupp JE; Aziz MA; Kinsella TJ; Loparo KA
    Cancer Res; 2007 Nov; 67(22):10993-1000. PubMed ID: 18006845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis.
    Yeung BH; Kwan BW; He QY; Lee AS; Liu J; Wong AS
    Oncogene; 2008 Dec; 27(53):6782-9. PubMed ID: 18776923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint.
    Wang RH; Yu H; Deng CX
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17108-13. PubMed ID: 15563594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1.
    Fan S; Yuan R; Ma YX; Meng Q; Goldberg ID; Rosen EM
    Oncogene; 2001 Dec; 20(57):8215-35. PubMed ID: 11781837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of MSH2 and MSH6 in cadmium-induced G2/M checkpoint arrest in Arabidopsis roots.
    Cao X; Wang H; Zhuang D; Zhu H; Du Y; Cheng Z; Cui W; Rogers HJ; Zhang Q; Jia C; Yang Y; Tai P; Xie F; Liu W
    Chemosphere; 2018 Jun; 201():586-594. PubMed ID: 29533809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation damage response in hematopoietic progenitor cells.
    Casorelli I; Pelosi E; Biffoni M; Cerio AM; Peschle C; Testa U; Bignami M
    DNA Repair (Amst); 2007 Aug; 6(8):1170-8. PubMed ID: 17507295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comet sensitivity in assessing DNA damage and repair in different cell cycle stages.
    McArt DG; McKerr G; Saetzler K; Howard CV; Downes CS; Wasson GR
    Mutagenesis; 2010 May; 25(3):299-303. PubMed ID: 20159793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6-Thioguanine-induced DNA damage as a determinant of cytotoxicity in cultured Chinese hamster ovary cells.
    Christie NT; Drake S; Meyn RE; Nelson JA
    Cancer Res; 1984 Sep; 44(9):3665-71. PubMed ID: 6204746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
    Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
    Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The human cyclin B1 protein modulates sensitivity of DNA mismatch repair deficient prostate cancer cell lines to alkylating agents.
    Rasmussen LJ; Rasmussen M; Lützen A; Bisgaard HC; Singh KK
    Exp Cell Res; 2000 May; 257(1):127-34. PubMed ID: 10854060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.